{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:25:43Z","timestamp":1765297543348,"version":"3.46.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,9]]},"DOI":"10.7759\/cureus.98802","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:20:51Z","timestamp":1765297251000},"source":"Crossref","is-referenced-by-count":0,"title":["C-reactive Protein Trends and Clinical Outcomes in Patients Treated for Complicated Parapneumonic Effusion and Empyema"],"prefix":"10.7759","author":[{"given":"John","family":"Ferguson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012740","article-title":"Intrapleural use of tissue plasminogen activator and DNase in pleural infection","volume":"365","author":"Rahman NM","year":"2011","unstructured":"Rahman NM, Maskell NA, West A, et al.. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011, 365:518-26. 10.1056\/NEJMoa1012740","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7539780","article-title":"The diagnostic value of the pleural fluid C-reactive protein in parapneumonic effusions","volume":"2016","author":"Izhakian S","year":"2016","unstructured":"Izhakian S, Wasser WG, Fox BD, Vainshelboim B, Kramer MR. The diagnostic value of the pleural fluid C-reactive protein in parapneumonic effusions. Dis Markers. 2016, 2016:7539780. 10.1155\/2016\/7539780","journal-title":"Dis Markers"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/arm93040029","article-title":"Diagnostic efficacy of C-reactive protein in differentiating various causes of exudative pleural effusion: disease research should not be exclusive to the wealthy","volume":"93","author":"Odeh M","year":"2025","unstructured":"Odeh M, Kogan Y, Sabo E. Diagnostic efficacy of C-reactive protein in differentiating various causes of exudative pleural effusion: disease research should not be exclusive to the wealthy. Adv Respir Med. 2025, 93:29. 10.3390\/arm93040029","journal-title":"Adv Respir Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-025-03799-3","article-title":"Association between serial changes in serum C-reactive protein levels and mortality among patients with pleural empyema: a database research","volume":"25","author":"Shiroshita A","year":"2025","unstructured":"Shiroshita A, Takeshita M, Nishiuma T, Ota T, Kataoka Y. Association between serial changes in serum C-reactive protein levels and mortality among patients with pleural empyema: a database research. BMC Pulm Med. 2025, 25:337. 10.1186\/s12890-025-03799-3","journal-title":"BMC Pulm Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2012(03)07","article-title":"Evaluation of serial C-reactive protein measurements after surgical treatment of pleural empyema","volume":"67","author":"Medeiros IL","year":"2012","unstructured":"Medeiros IL, Terra RM, Choi EM, Pego-Fernandes PM, Jatene FB. Evaluation of serial C-reactive protein measurements after surgical treatment of pleural empyema. Clinics (Sao Paulo). 2012, 67:243-7. 10.6061\/clinics\/2012(03)07","journal-title":"Clinics (Sao Paulo)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1558","article-title":"A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection","volume":"145","author":"Rahman NM","year":"2014","unstructured":"Rahman NM, Kahan BC, Miller RF, Gleeson FV, Nunn AJ, Maskell NA. A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest. 2014, 145:848-55. 10.1378\/chest.13-1558","journal-title":"Chest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-022-01995-z","article-title":"Modified regimen intrapleural alteplase with pulmozyme in pleural infection management: a tertiary teaching hospital experience","volume":"22","author":"Cheong XK","year":"2022","unstructured":"Cheong XK, Ban AY, Ng BH, et al.. Modified regimen intrapleural alteplase with pulmozyme in pleural infection management: a tertiary teaching hospital experience. BMC Pulm Med. 2022, 22:199. 10.1186\/s12890-022-01995-z","journal-title":"BMC Pulm Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2008.08.012","article-title":"Recombinant tissue plasminogen activator in the treatment of pleural infections in adults","volume":"102","author":"Froudarakis ME","year":"2008","unstructured":"Froudarakis ME, Kouliatsis G, Steiropoulos P, et al.. Recombinant tissue plasminogen activator in the treatment of pleural infections in adults. Respir Med. 2008, 102:1694-700. 10.1016\/j.rmed.2008.08.012","journal-title":"Respir Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02856.x","article-title":"Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia","volume":"15","author":"Hohenthal U","year":"2009","unstructured":"Hohenthal U, Hurme S, Helenius H, Heiro M, Meurman O, Nikoskelainen J, Kotilainen P. Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia. Clin Microbiol Infect. 2009, 15:1026-32. 10.1111\/j.1469-0691.2009.02856.x","journal-title":"Clin Microbiol Infect"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.72112","article-title":"C-reactive protein variation and its usefulness in the prognostication and monitoring of patients with pneumococcal pneumonia","volume":"16","author":"Gomes A","year":"2024","unstructured":"Gomes A, Ribeiro R, Froes F, Mergulh\u00e3o P, Gon\u00e7alves Pereira J. C-reactive protein variation and its usefulness in the prognostication and monitoring of patients with pneumococcal pneumonia. Cureus. 2024, 16:e72112. 10.7759\/cureus.72112","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.108.5.1288","article-title":"C-reactive protein. A clinical marker in community-acquired pneumonia","volume":"108","author":"Smith RP","year":"1995","unstructured":"Smith RP, Lipworth BJ, Cree IA, Spiers EM, Winter JH. C-reactive protein. A clinical marker in community-acquired pneumonia. Chest. 1995, 108:1288-91. 10.1378\/chest.108.5.1288","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.10.033","article-title":"C-reactive protein is an independent predictor of severity in community-acquired pneumonia","volume":"121","author":"Chalmers JD","year":"2008","unstructured":"Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med. 2008, 121:219-25. 10.1016\/j.amjmed.2007.10.033","journal-title":"Am J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/439916-c-reactive-protein-trends-and-clinical-outcomes-in-patients-treated-for-complicated-parapneumonic-effusion-and-empyema","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:20:52Z","timestamp":1765297252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/439916-c-reactive-protein-trends-and-clinical-outcomes-in-patients-treated-for-complicated-parapneumonic-effusion-and-empyema"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.98802","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,9]]}}}